This is generally a surface-level event and does not mean the medication is being absorbed incorrectly
Of note, GLP-1 secretion in the blood increased with -glucan and showed an increasing trend with arabinoxylan, suggesting barley -glucan and arabinoxylan are fermented in the intestinal tract to favor endogenous GLP-1 release [30], thus mimicking SG effects
It changes the structure of the receptor slightly, which means semaglutide may not bind as effectively or trigger the same downstream signaling cascade in your cells
Dose changes can affect nausea, vomiting, dehydration risk, glucose control, and other medicines
Weight loss can affect an individuals ability to lose and maintain a healthy weight
In severe dysmetabolism, neutrophil extracellular traps-derived cell-free DNA and IL-6 trans-signaling rise and track with carotid remodeling and impaired FMD (170, 171)